NEXT＞＞

Vol. 38 Suppl. 1 2010

【Japan Society of Clinical Trials and Research】

■ SYMPOSIUM

【Symposium 1：Progress in PGx】

Development of diagnostic kit for UGT1A1 gene

A. Mori, et al.

Jpn Pharmacol Ther 2010　38(s1) s16-9

---

Design of phase I trial for individualized dose level based on UGT1A1 testing

N. Ishizuka

Jpn Pharmacol Ther 2010　38(s1) s20-1

---

Tasks for generalizing PGx-based pharmacotherapy

Y. Uyama

Jpn Pharmacol Ther 2010　38(s1) s22-5

---

Points to consider of pharmacogenomics application in clinical trials (final draft)

T. Ichihara

Jpn Pharmacol Ther 2010　38(s1) s26-9

---

Prospect of PGx in new drug development

N. Kamatani

Jpn Pharmacol Ther 2010　38(s1) s30-2

---

PGx in clinical institution

H. Watanabe

Jpn Pharmacol Ther 2010　38(s1) s33-5

---

【Symposium2：How to improve support system for investigator initiated clinical trials?】

Clinical research service in the University of Tokyo Hospital

Y. Arakawa

Jpn Pharmacol Ther 2010　38(s1) s36-40

---

The current situation and challenges with management of clinical studies supported by Translational Research Informatics Center

K. Matsuyama, et al.

Jpn Pharmacol Ther 2010　38(s1) s41-5

---

From physician’s point of view of clinical data management

S. Hinotsu

Jpn Pharmacol Ther 2010　38(s1) s46-8

---

A approach from a biostatistician of clinical research

H.Ohtsu

Jpn Pharmacol Ther 2010　38(s1) s49-51

---

Coordinating protocol development in investigator initiated clinical trials

M. Niimi

Jpn Pharmacol Ther 2010　38(s1) s52-3

■ ORIGINAL ARTICLES

First attempt of large phase III oncology trial using Japanese new trial evaluation system, the Evaluation System of Investigational Medical Care

E. Aotani, et al.

Jpn Pharmacol Ther 2010　38(s1) s59-64